Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response

by Hong Yuen Wong, Anthony D. Sung, Katherine E. Lindblad, Sheenu Sheela, Gregory W. Roloff, David Rizzieri, Meghali Goswami, Matthew P. Mulé, Nestor R. Ramos, Jingrong Tang, Julie Thompson, Christin B. DeStefano, Kristi Romero, Laura W. Dillon, Dong-Yun Kim, Catherine Lai, Christopher S. Hourigan
Published 2019-01-01

Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality.

by Ko Maung, Sendhilnathan Ramalingam, Mohammad Chaudhry, Yi Ren, Sin-Ho Jung, Kristi Romero, Kelly Corbet, Nelson J Chao, Taewoong Choi, Anna Mae Diehl, Louis Diehl, Cristina Gasparetto, Mitchell Horwitz, Gwynn Douglas Long, Richard D Lopez, David A Rizzieri, Stefanie Sarantopoulos, Keith M Sullivan, Mustafa R Bashir, Anthony D Sung
Published 2020-01-01

Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality

by Ko Maung, Sendhilnathan Ramalingam, Mohammad Chaudhry, Yi Ren, Sin-Ho Jung, Kristi Romero, Kelly Corbet, Nelson J. Chao, Taewoong Choi, Anna Mae Diehl, Louis Diehl, Cristina Gasparetto, Mitchell Horwitz, Gwynn Douglas Long, Richard D. Lopez, David A. Rizzieri, Stefanie Sarantopoulos, Keith M. Sullivan, Mustafa R. Bashir, Anthony D. Sung, Gianfranco D. Alpini
Published 2020-01-01